Health Equity in Clinical Trials: Patient Navigation Plays an Integral Role

Guardant Health Perspective  | Jul 13, 2023
Author:
Guardant Health Blog Team

Clinical trials are a critical step in developing new treatments and medications and a crucial tool for evaluating the safety and efficacy of existing treatments.6 However, for clinical trials to be successful, they must be conducted with a focus on equity and inclusion. Equity in clinical trials is integral to advancing research, ensuring positive patient outcomes, and promoting overall public health.1

Health Equity in Clinical Trials 

Equity in clinical trials means ensuring that diverse populations have equal access to and participation in clinical research. This includes individuals from underrepresented populations, such as women, minorities, and those from low-income backgrounds.1 The absence of these populations in clinical trials can lead to a lack of understanding of how treatments and medications will impact these groups, potentially leading to disparities in patient outcomes.2-5 

The Importance of Patient Navigation 

To achieve equity in clinical trials, it is essential to involve patient navigation services. Patient navigation is the process of guiding and supporting patients through the healthcare system, including the clinical trial process.8 Navigators can help individuals understand the benefits and risks of participating in a clinical trial, assist with obtaining informed consent, and provide ongoing support throughout the trial. Navigators can also help address barriers to participation, such as transportation, childcare, and time off from work.9-11

Patient navigation is vital for underrepresented populations, as they may face unique challenges in accessing and participating in clinical trials.7 For example, individuals from low-income backgrounds may not have access to transportation or may face language barriers. Navigators can help address these challenges, making clinical trials more accessible and equitable for all patients.2, 9-12 

Successful Clinical Trials 

In addition to improving equity in clinical trials, patient navigation can also improve the overall success of clinical trials. By providing support and assistance throughout the trial, navigators can help increase patient engagement, treatment plan adherence, and overall trial process satisfaction. This can lead to a higher rate of successful completion of trials and more accurate results.9-11 

In conclusion, equity in clinical trials is essential for advancing research and promoting positive patient outcomes. Patient navigation services can play a critical role in achieving equity by addressing barriers to participation, increasing patient engagement and satisfaction, and ensuring that diverse populations are represented in clinical trials. By working together, clinical researchers and patient navigation services can help advance medical research and improve public health for all individuals.

About the author

Guardant Health Blog Team

Recommended Stories
In the News |  December 9, 2024

The 50 greatest innovations of 2024: Shield Blood Test

Read More
In the News |  December 5, 2024

Blood tests for cancer are here and Guardant Health is leading th...

Read More
In the News |  October 30, 2024

TIME’s Best Inventions of 2024: Shield Blood Test

Read More
  1. Eggly, S., Barton, E., Winckles, A., Penner, L.A. and Albrecht, T.L. (2015), A disparity of words: racial differences in oncologist–patient communication about clinical trials. Health Expect, 18: 1316-1326. https://doi.org/10.1111/hex.12108
  2. Fouad MN. Enrollment of minorities in clinical trials: did we overcome the barriers? Contemporary Clinical Trials, 2009; 30: 103–104.
  3. Bolen S, Tilburt J, Baffi C et al. Defining “success” in recruitment of underrepresented populations to cancer clinical trials: moving toward a more consistent approach. Cancer, 2006; 106: 1197–1204.
  4. Hewitt ME, Simone JV, National Cancer Policy Board (U.S.). Ensuring Quality Cancer Care. Washington, DC: National Academy Press, 1999.
  5. Nass SJ, Moses HL, Mendelsohn J. A National Cancer Clinical Trials System for the 21st Century: Reinvigorating the NCI Cooperative Group Program Institute of Medicine, Committee on Cancer Clinical Trials and the NCI Cooperative Group Program, 2010.
  6. “What Are Clinical Trials and Studies?” National Institute on Aging, U.S. Department of Health and Human Services, https://www.nia.nih.gov/health/what-are-clinical-trials-and-studies.
  7. Patient Navigation As a Model to Increase Participation of African Americans in Cancer Clinical Trials. Mona N. Fouad, Aras Acemgil, Sejong Bae, Andres Forero, Nedra Lisovicz, Michelle Y. Martin, Gabriela R. Oates, Edward E. Partridge, and Selwyn M. Vickers Journal of Oncology Practice 2016 12:6, 556-563
  8. Tang KL, Ghali WA. Patient Navigation—Exploring the Undefined. JAMA Health Forum. 2021;2(11):e213706. doi:10.1001/jamahealthforum.2021.3706
  9. CR Baquet, K Henderson, P Commiskey, etal: Clinical trials: The art of enrollment Semin Oncol Nurs 24:262–269,2008 Crossref, Medline, Google Scholar
  10. Brown DR, Fouad MN, Basen-Engquist K, et al: Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol 10:S13-S21, 2000 (suppl 8) Google Scholar
  11. ED Paskett, ML Katz, CR DeGraffinreid, etal: Participation in cancer trials: Recruitment of underserved populations Clin Adv Hematol Oncol 1:607–613,2003 Medline, Google Scholar
  12. Durant RW, Wenzel JA, Scarinci IC, et al: Perspectives on barriers and facilitators to minority recruitment for clinical trials among cancer center leaders, investigators, research staff, and referring clinicians: Enhancing minority participation in clinical trials (EMPaCT). Cancer 120:1097-1105, 2014 (suppl 7) Google Scholar